Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications

Ana Teresa A Amaral, Maria Cristina Manara, Dagmar Berghuis, José Luis Ordóñez, Michele Biscuola, Maria Angeles Lopez-García, Daniel Osuna, Enrico Lucarelli, Francesco Alviano, Arjan Lankester, Katia Scotlandi, Enriquede De Álava

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin. Materials and Methods: In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples. Results: We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99. Conclusions: In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis.

Original languageEnglish
Article numbere85814
JournalPLoS One
Volume9
Issue number2
DOIs
Publication statusPublished - Feb 3 2014

Fingerprint

Ewing's Sarcoma
sarcoma
Stem cells
Mesenchymal Stromal Cells
stem cells
Genes
gene fusion
Gene Rearrangement
Gene Fusion
cells
Fusion reactions

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Amaral, A. T. A., Manara, M. C., Berghuis, D., Ordóñez, J. L., Biscuola, M., Lopez-García, M. A., ... De Álava, E. (2014). Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications. PLoS One, 9(2), [e85814]. https://doi.org/10.1371/journal.pone.0085814

Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications. / Amaral, Ana Teresa A; Manara, Maria Cristina; Berghuis, Dagmar; Ordóñez, José Luis; Biscuola, Michele; Lopez-García, Maria Angeles; Osuna, Daniel; Lucarelli, Enrico; Alviano, Francesco; Lankester, Arjan; Scotlandi, Katia; De Álava, Enriquede.

In: PLoS One, Vol. 9, No. 2, e85814, 03.02.2014.

Research output: Contribution to journalArticle

Amaral, ATA, Manara, MC, Berghuis, D, Ordóñez, JL, Biscuola, M, Lopez-García, MA, Osuna, D, Lucarelli, E, Alviano, F, Lankester, A, Scotlandi, K & De Álava, E 2014, 'Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications', PLoS One, vol. 9, no. 2, e85814. https://doi.org/10.1371/journal.pone.0085814
Amaral, Ana Teresa A ; Manara, Maria Cristina ; Berghuis, Dagmar ; Ordóñez, José Luis ; Biscuola, Michele ; Lopez-García, Maria Angeles ; Osuna, Daniel ; Lucarelli, Enrico ; Alviano, Francesco ; Lankester, Arjan ; Scotlandi, Katia ; De Álava, Enriquede. / Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications. In: PLoS One. 2014 ; Vol. 9, No. 2.
@article{e5ea88a2b22647d38b266367fd38decd,
title = "Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications",
abstract = "Background: Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin. Materials and Methods: In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples. Results: We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99. Conclusions: In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis.",
author = "Amaral, {Ana Teresa A} and Manara, {Maria Cristina} and Dagmar Berghuis and Ord{\'o}{\~n}ez, {Jos{\'e} Luis} and Michele Biscuola and Lopez-Garc{\'i}a, {Maria Angeles} and Daniel Osuna and Enrico Lucarelli and Francesco Alviano and Arjan Lankester and Katia Scotlandi and {De {\'A}lava}, Enriquede",
year = "2014",
month = "2",
day = "3",
doi = "10.1371/journal.pone.0085814",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications

AU - Amaral, Ana Teresa A

AU - Manara, Maria Cristina

AU - Berghuis, Dagmar

AU - Ordóñez, José Luis

AU - Biscuola, Michele

AU - Lopez-García, Maria Angeles

AU - Osuna, Daniel

AU - Lucarelli, Enrico

AU - Alviano, Francesco

AU - Lankester, Arjan

AU - Scotlandi, Katia

AU - De Álava, Enriquede

PY - 2014/2/3

Y1 - 2014/2/3

N2 - Background: Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin. Materials and Methods: In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples. Results: We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99. Conclusions: In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis.

AB - Background: Ewing Sarcoma (EWS) is a mesenchymal-derived tumor that generally arises in bone and soft tissue. Intensive research regarding the pathogenesis of EWS has been insufficient to pinpoint the early events of Ewing sarcomagenesis. However, the Mesenchymal Stem Cell (MSC) is currently accepted as the most probable cell of origin. Materials and Methods: In an initial study regarding a deep characterization of MSC obtained specifically from EWS patients (MSC-P), we compared them with MSC derived from healthy donors (MSC-HD) and EWS cell lines. We evaluated the presence of the EWS-FLI1 gene fusion and EWSR1 gene rearrangements in MSC-P. The presence of the EWS transcript was confirmed by q-RT-PCR. In order to determine early events possibly involved in malignant transformation, we used a multiparameter quantitative strategy that included both MSC immunophenotypic negative/positive markers, and EWS intrinsic phenotypical features. Markers CD105, CD90, CD34 and CD45 were confirmed in EWS samples. Results: We determined that MSC-P lack the most prevalent gene fusion, EWSR1-FLI1 as well as EWSR1 gene rearrangements. Our study also revealed that MSC-P are more alike to MSC-HD than to EWS cells. Nonetheless, we also observed that EWS cells had a few overlapping features with MSC. As a relevant example, also MSC showed CD99 expression, hallmark of EWS diagnosis. However, we observed that, in contrast to EWS cells, MSC were not sensitive to the inhibition of CD99. Conclusions: In conclusion, our results suggest that MSC from EWS patients behave like MSC-HD and are phenotypically different from EWS cells, thus raising important questions regarding MSC role in sarcomagenesis.

UR - http://www.scopus.com/inward/record.url?scp=84895474171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895474171&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0085814

DO - 10.1371/journal.pone.0085814

M3 - Article

C2 - 24498265

AN - SCOPUS:84895474171

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e85814

ER -